Sun Biopharma Inc. | Income Statement
Fiscal year is January-December. All values USD Thousands.
2013
2014
2015
2016
2017
2018
Sales/Revenue
973.80
1,357.00
-
-
-
3,891
Cost of Goods Sold (COGS) incl. D&A
558.50
595.20
-
-
-
-
Gross Income
415.30
761.80
-
-
-
-
SG&A Expense
609.70
837.20
5,119.00
5,168.00
6,016.00
3,891
EBIT
194.30
75.40
-
5,168.00
6,016.00
3,891
Unusual Expense
-
-
325.00
-
3,696.00
-
Non Operating Income/Expense
-
-
64.00
107.00
255.00
508
Interest Expense
35.90
35.50
183.00
180.00
1,617.00
1,814
Pretax Income
211.80
106.90
5,683.00
5,453.00
10,910.00
6,159
Income Tax
0.20
0.10
756.00
341.00
536.00
254
Consolidated Net Income
212.00
107.00
4,927.00
5,112.00
10,374.00
5,905
Net Income
212.00
107.00
4,927.00
5,112.00
10,374.00
5,905
Net Income After Extraordinaries
212.00
107.00
4,927.00
5,112.00
10,374.00
5,905
Net Income Available to Common
212.00
107.00
4,927.00
5,112.00
10,374.00
5,905
EPS (Basic)
1.46
0.74
3.50
1.60
2.91
1.27
Basic Shares Outstanding
145.00
145.00
1,407.30
3,106.90
3,566.10
4,662.10
EPS (Diluted)
1.46
0.74
3.50
1.65
2.91
1.27
Diluted Shares Outstanding
145.00
145.00
1,407.30
3,106.90
3,566.10
4,662.10
EBITDA
185.50
65.80
5,119.00
5,168.00
6,016.00
-
Non-Operating Interest Income
18.40
4.00
8.00
2.00
1.00
-
About Sun Biopharma
View Profile
